MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0057573
Ravi Biolife Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.49 Cr
Latest filing
Net loss · FY 2025
₹7.59 Cr
Net margin -116.9%
EBITDA · FY 2025
-₹4.5 Cr
EBITDA margin -69.3%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹5.01 Cr
Issued & subscribed
Open charges
₹7 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
71
Provident fund records
About Ravi Biolife Private Limited
Data last updated:
Ravi Biolife Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ravi Pharmascience Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2020PTC352827. Its GSTIN is 27AAKCR7053H1Z2 (Maharashtra).
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹5.01 Cr. It is led by directors including Vinod Singhania and Siddharth Singhania.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.49 Cr. For the same year it recorded a net loss of ₹7.59 Cr (net margin -116.9%) and EBITDA of -₹4.5 Cr (EBITDA margin -69.3%).
The company has about 71 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹7 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending. The company has 3 deals on record (1 debt financing, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹22.5 Cr; the latest was in November 2021. Its 7 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Anant Pharmaceuticals Private Limited with revenue of ₹6.76 Cr.
Ravi Biolife Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0057573). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ravidyeware.com.
Company details
CIN U24299MH2020PTC352827
Registration Number 352827
Incorporation Date 31 December 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Ravi Pharmascience Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0057573
Recognitions & Rankings of Ravi Biolife
Contact details
Ravi Biolife Private Limited's registered office is in Mumbai, Maharashtra. Its website is ravidyeware.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ravi Biolife Private Limited, buy the company report.
Comprehensive company report
Ravi Biolife Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ravi Biolife is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ravi Biolife Private Limited, buy the company report.
Financials of Ravi Biolife Private Limited
FY 2025 filings availableRavi Biolife Private Limited reported revenue of ₹6.49 Cr for FY 2025.
Revenue · FY 2025
₹6.49 Cr
Net loss · FY 2025
₹7.59 Cr margin -116.9%
EBITDA · FY 2025
-₹4.5 Cr margin -69.3%
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -69.3% | ||||
| Net Profit Margin | -116.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ravi Biolife Private Limited, buy the company report.
Board of directors of Ravi Biolife Private Limited
Ravi Biolife has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Singhania Also directs: Unique Dreamscape LLP, Mountview Properties Limited Liability Partnership, Helion Mercantile LLP and 5 more | Director | 31 Dec 2020 | 5 Years 9 Months | Current |
| Siddharth Singhania | Director | 31 Dec 2020 | 5 Years 9 Months | Current |
| Harshvardhan Singhania Also directs: Abhavi Mercantile LLP, H&A Property Holding LLP, Melody Healthcare Private Limited and 3 more | Director | 16 Oct 2024 | 2 Years 0 Months | Current |
| Devang Rajesh Singhania Also directs: C A P A (India) LLP, Siddharth Colorchem Private Limited, Melody Healthcare Private Limited and 2 more | Director | 01 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Ravi Biolife Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | 7.0% | Ambernath East, Maharashtra, India | |||
| HTS Biopharma Private Limited | ₹6.71 Cr (FY 2024) | 7.0% | Hyderabad, Telangana, India | |||
| Abhinandan Rasayan Private Limited | ₹6.66 Cr (FY 2018) | -37.0% | Dombivli East, Maharashtra, India | |||
| Alchem Synthon Private Limited. | ₹6.53 Cr (FY 2025) | -17.0% | Thane, Maharashtra, India | |||
| Ravi Biolife Private Limitedthis company | ₹6.49 Cr (FY 2025) | -₹7.59 Cr | -116.9% | 71 | Mumbai, Maharashtra, India | |
| Healthgenic Chemicals Private Limited | ₹6.49 Cr (FY 2025) | -24.0% | Morbi, Gujarat, India | |||
| Neha Life Science Private Limited | ₹6.41 Cr (FY 2025) | 34.0% | Ahmedabad, Gujarat, India | |||
| Bihani Chemical Industries Pvt Ltd | ₹6.31 Cr (FY 2025) | 21.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Ravi Biolife Private Limited, buy the company report.
Auditor
Ravi Biolife Private Limited is audited by M. A. Parikh Shah & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M. A. Parikh Shah & Associates | FY 2023 | 107556W |
Shareholding
The shareholding of Ravi Biolife Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ravi Biolife Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Dec 2024 | 101037434 | Axis Bank Limited | ₹7 Cr | Open |
To see the full charge records of Ravi Biolife Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Ravi Biolife Private Limited has 3 deals on record (1 debt financing, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹22.5 Cr; the latest was in November 2021.
Total deals
3
Debt financing
1
Funding round
1
Secondary share transfer
1
Disclosed funding
₹22.5 Cr
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Debt financing | ₹17.5 Cr | Investors: Melody Health Care Private Limited |
| Jul 2021 | Funding round | ₹5 Cr | Investors: Ravi Dyeware Company Private Limited |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Ravi Pharma Science Private Limited, Siddharth Colorchem Private Limited , 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ravi Biolife Private Limited has 3 court cases on record: 1 filed by Ravi Biolife, 2 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
1
Filed against the company
2
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 2 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ravi Dyeware Company Private Limited | Disposed |
| District court, Raigad, Maharashtra | Civil suit | Filed against the company by M R Nikam Inspector Under Maharashtra Private Security Guards Board Raigad | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
To see the full case history of Ravi Biolife Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ravi Biolife Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ravi Biolife Private Limited has a workforce of 71 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
71
Active EPFO establishments
1
Employee growth
20.34%
GST
Ravi Biolife has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCR7053H1Z2 | Maharashtra | Active | 24 Feb 2021 |
To see the full GST registrations and return filing status of Ravi Biolife Private Limited, buy the company report.
Recent activity
Ravi Biolife Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Harshvardhan Singhania ceased to be Additional Director on 26 Sep 2025.
AGM
Ravi Biolife Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Ceased
Harshvardhan Singhania ceased to be Additional Director.
Charges
A charge with Axis Bank Limited of Rs. 7.00 Cr registered on 31 Dec 2024 with Charge ID 101037434 was modified on 19 Apr 2025.
Filing
Ravi Biolife Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Axis Bank Limited amounted to Rs. 7.00 Cr with Charge ID 101037434 was registered on 31 Dec 2024.
Appointed
Harshvardhan Singhania was appointed as Director.
Ceased
Devang Rajesh Singhania ceased to be Additional Director.
Appointed
Devang Rajesh Singhania was appointed as Director.
Appointed
Siddharth Singhania was appointed as Director.
Appointed
Vinod Singhania was appointed as Director.
Incorporation
31 Dec 2020
Ravi Biolife Private Limited was registered on 31 Dec 2020 with Roc Mumbai I & aged 5 years 9 months as per MCA records.
Frequently asked questions
Ravi Biolife is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 December 2020 (6+ years old) and is registered under CIN U24299MH2020PTC352827.
Ravi Biolife has 4 current directors:
- Vinod Singhania - Director
- Siddharth Singhania - Director
- Harshvardhan Singhania - Director
- Devang Rajesh Singhania - Director
The latest financial statements of Ravi Biolife on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ravi Biolife is 27AAKCR7053H1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ravi Biolife is U24299MH2020PTC352827. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ravi Biolife has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending. Most are in the district courts.
Ravi Biolife was incorporated on 31 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Ravi Biolife has 3 deals on record (1 debt financing, 1 funding round, 1 secondary share transfer), with disclosed funding of ₹22.5 Cr; the latest was in November 2021.
The peers of Ravi Biolife by revenue are Anant Pharmaceuticals Private Limited, HTS Biopharma Private Limited, Abhinandan Rasayan Private Limited, Alchem Synthon Private Limited, Healthgenic Chemicals Private Limited and 2 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harshvardhan Singhania ceased to be Additional Director on 26 Sep 2025. Harshvardhan Singhania was appointed as Director on 16 Oct 2024. Devang Rajesh Singhania ceased to be Additional Director on 30 Dec 2021. Ravi Biolife has 6 board changes on record in total.
Yes, Ravi Biolife is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0057573).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages